Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.
4.

Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.

Mashiba T, Hui S, Turner CH, Mori S, Johnston CC, Burr DB.

Calcif Tissue Int. 2005 Sep;77(3):180-5. Epub 2005 Sep 8.

PMID:
16265598
5.

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB.

J Bone Miner Res. 2000 Apr;15(4):613-20.

6.

Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.

Burr DB, Miller L, Grynpas M, Li J, Boyde A, Mashiba T, Hirano T, Johnston CC.

Bone. 2003 Dec;33(6):960-9.

PMID:
14678856
7.

Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.

Komatsubara S, Mori S, Mashiba T, Li J, Nonaka K, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanishi J, Norimatsu H.

J Bone Miner Res. 2004 Jun;19(6):999-1005. Epub 2004 Jan 19.

8.

Increased intracortical remodeling following fatigue damage.

Mori S, Burr DB.

Bone. 1993 Mar-Apr;14(2):103-9.

PMID:
8334026
9.

Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.

Follet H, Li J, Phipps RJ, Hui S, Condon K, Burr DB.

Bone. 2007 Apr;40(4):1172-7. Epub 2006 Dec 19.

PMID:
17240209
10.

Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.

Day JS, Ding M, Bednarz P, van der Linden JC, Mashiba T, Hirano T, Johnston CC, Burr DB, Hvid I, Sumner DR, Weinans H.

J Orthop Res. 2004 May;22(3):465-71.

11.

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

Allen MR, Turek JJ, Phipps RJ, Burr DB.

Bone. 2011 Jul;49(1):128-32. doi: 10.1016/j.bone.2010.07.011. Epub 2010 Jul 15.

PMID:
20637914
12.

Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.

Yamagami Y, Mashiba T, Iwata K, Tanaka M, Nozaki K, Yamamoto T.

Bone. 2013 May;54(1):1-7. doi: 10.1016/j.bone.2013.01.016. Epub 2013 Jan 26.

PMID:
23356990
13.

Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?

Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB.

Bone. 2000 Jul;27(1):13-20.

PMID:
10865204
14.

Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

Wang X, Erickson AM, Allen MR, Burr DB, Martin RB, Hazelwood SJ.

J Biomech. 2009 May 11;42(7):938-44. doi: 10.1016/j.jbiomech.2008.07.039. Epub 2009 Mar 12.

15.

A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.

Nyman JS, Yeh OC, Hazelwood SJ, Martin RB.

Bone. 2004 Jul;35(1):296-305.

PMID:
15207770
16.

Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.

Komatsubara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanishi J, Norimatsu H.

J Bone Miner Res. 2003 Mar;18(3):512-20.

17.
18.

Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures.

Mashiba T, Turner CH, Hirano T, Forwood MR, Jacob DS, Johnston CC, Burr DB.

Bone. 2001 Sep;29(3):271-8.

PMID:
11557372
19.

Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.

Allen MR, Erickson AM, Wang X, Burr DB, Martin RB, Hazelwood SJ.

Calcif Tissue Int. 2010 Jan;86(1):67-71. doi: 10.1007/s00223-009-9315-x. Epub 2009 Dec 2.

20.

Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.

Brennan O, Kennedy OD, Lee TC, Rackard SM, O'Brien FJ.

J Orthop Res. 2011 Mar;29(3):419-24. doi: 10.1002/jor.21229. Epub 2010 Sep 30.

Supplemental Content

Support Center